Orphan Drugs
The promotion and development of medicinal products for the treatment of rare diseases require our particular attention, as health is our most valuable possession, " said Ursula Schleicher, former Vice-President of the European Parliament.According to estimates, around 25 million people in Europe are suffering from 5, 000 to 8, 000 orphan diseases. Many of them are still waiting for medicines ...